アレルギー免疫療法市場レポート：2023-2033
Allergy Immunotherapy Market Report 2023-2033
レポート詳細
アレルギー免疫療法市場レポート 2023-2033年： 本レポートは、業界とその基礎となる原動力をより良く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるで... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
アレルギー免疫療法市場レポート 2023-2033年：本レポートは、業界とその基礎となる原動力をより良く理解したい場合、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。異業種への進出や新規地域での既存事業の拡大を目指す企業にも有用です。
アレルギー免疫療法技術の著しい進歩が業界を前進させている。皮下免疫療法（SCIT）や舌下免疫療法（SLIT）の導入により治療の選択肢が広がり、患者にとって免疫療法がより身近で便利なものとなった。さらに、アレルゲン特異的免疫療法や、組み換えアレルゲンやアジュバントなどの改良型製剤の開発により、治療の有効性と安全性が向上している。
特に先進国における医療費の増加は、アレルギー免疫療法産業の成長に寄与している。個人や医療制度が予防医療や慢性疾患の長期管理を優先する中、アレルギー免疫療法は費用対効果の高いアプローチとして認知されてきた。このため、需要の増加に対応するための研究、技術革新、インフラへの投資が活発化している。
市場調査レポートを購入する前にすべき質問とは？
- アレルギー免疫療法市場はどのように進化しているのか？
- アレルギー免疫療法市場の促進要因と抑制要因は何か？
- 各アレルギー免疫療法サブマーケットセグメントは予測期間中にどのように成長し、2033年にはどれくらいの売上を占めるようになるのか？
- 2023年から2033年にかけて、各アレルギー免疫療法サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて市場全体を牽引する主要因は何か？
- 主要なアレルギー免疫療法市場はマクロ経済ダイナミクスに概ね追随するのか、それとも個々の国市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年にはどの地域が市場をリードするのか？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- これら主要企業のアレルギー免疫療法プロジェクトとは？
- 2023年から2033年の間に、業界はどのように発展していくのか？現在進行中のアレルギー免疫療法プロジェクトが
現在および今後10年間に実施されるアレルギー免疫療法プロジェクトはどのような意味を持つのか？
- アレルギー免疫療法市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
- アレルギー免疫療法市場はどこに向かっているのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
このことが、現在、そして今後10年間のアレルギー免疫療法市場にどのような影響を与えるかを見極める必要がある：
- 187ページにわたる本レポートでは、89の表と120の図表を掲載しています。
- 本レポートは、業界における主要な有利分野にハイライトを当てているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、アレルギー免疫療法市場が今後10年間でどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展するかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要である。
2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
治療タイプ
- 皮下免疫療法（SCIT）
- 舌下免疫療法（SLIT）
アレルギータイプ
- アレルギー性鼻炎
- 喘息
- その他
販売チャネル
- 病院薬局
- 小売薬局
- オンライン薬局
世界市場全体とセグメント別の収益予測に加え、5つの地域と20の主要国市場の収益予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他のヨ欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他ラテンアメリカ
MEA
- GCC
- 南アフリカ
- その他のMEA
本レポートには、アレルギー免疫療法市場の主要企業のプロファイルと2023年から2033年までの市場推移も掲載されている。
主要企業と市場成長の可能性
・ Aimmune Therapeutics
・ ALK-Abelló A/S
・ Adamis Pharmaceuticals Corporation
・ Allergy Therapeutics
・ Allergopharma
・ DBV Technologies
・ DESENTUM OY
・ HAL Allergy B.V.
・ HISHOH Biopharma
・ HollisterStier Allergy (Jubilant Pharma Company)
・ LETI Pharma
・ Stallergenes Greer
アレルギー免疫療法市場全体の世界売上高（金額ベース）は、2023年から2033年にかけて20億2,100万米ドルを超えると予測。2033年まで力強い収益成長を予測。当研究所では、最も大きな可能性を秘めた組織を特定する。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。
アレルギー免疫療法市場、2023-2033年レポートはどのように役立ちますか？
要約すると、180ページを超えるこのレポートは、以下の知識を提供する：
- アレルギー免疫療法市場の2023年から2033年までの収益予測 世界および地域レベルで、治療タイプ、アレルギータイプ、流通チャネルごとに予測 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけます。
- 5つの地域と20の主要国市場の2033年までの収益予測 - 北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAのアレルギー免疫療法市場の2023年から2033年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなど著名な経済圏の市場も予測しています。
- 2023年から2033年までのアレルギー免疫療法市場に関わる主要企業12社の企業プロファイルを含む。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社の調査レポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、アレルギー免疫療法市場、2023年から2033年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 アレルギー免疫療法市場の紹介
1.3 本レポートの特徴
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通り
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 各種アレルギーの負担増
3.2.1.2 新興国における新しい舌下免疫療法の発売
3.2.1.3 アレルギー性鼻炎および喘息患者の増加
3.2.2 市場抑制要因
3.2.2.1 アレルギーとその治療法に関する認識不足
3.2.2.2 アレルギー免疫療法の使用に伴う欠点
3.2.3 市場機会
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 供給者の交渉力
3.4.2 買い手のバイヤーパワー
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 アレルギー免疫療法市場分析：治療タイプ別
4.1 主要な調査結果
4.2 治療タイプ別セグメント 市場魅力度指標
4.3 治療タイプ別アレルギー免疫療法市場規模の推定と予測
4.4 皮下免疫療法（SCIT）
4.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
4.4.2 地域別市場シェア、2023年・2033年 (%)
4.5 舌下免疫療法（SLIT）
4.5.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
4.5.2 地域別市場シェア、2023年・2033年 (%)
5 アレルギー免疫療法市場分析：アレルギータイプ別
5.1 主要調査結果
5.2 アレルギータイプ別セグメント 市場魅力度指数
5.3 アレルギー免疫療法のアレルギータイプ別市場規模推定と予測
5.4 アレルギー性鼻炎
5.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
5.4.2 地域別市場シェア、2023年・2033年 (%)
5.5 喘息
5.5.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.5.2 地域別市場シェア、2023年・2033年 (%)
5.6 その他
5.6.1 2023〜2033年の地域別市場予測 (US$ Mn, AGR %)
5.6.2 地域別市場シェア、2023年・2033年 (%)
6 アレルギー免疫療法市場分析：流通チャネル別
6.1 主な調査結果
6.2 流通チャネルセグメント 市場魅力度指数
6.3 流通チャネル別アレルギー免疫療法の市場規模推定と予測
6.4 病院薬局
6.4.1 2023〜2033年の地域別市場予測（US$ Mn, AGR %)
6.4.2 地域別市場シェア、2023年・2033年 (%)
6.5 小売薬局
6.5.1 2023年～2033年の地域別市場予測 (US$ Mn, AGR %)
6.5.2 地域別市場シェア、2023年・2033年(%)
6.6 オンライン薬局
6.6.1 2023～2033年の地域別市場予測（US$ Mn, AGR %)
6.6.2 地域別市場シェア、2023年・2033年 (%)
7 アレルギー免疫療法市場分析：地域別
7.1 主要な調査結果
7.2 地域別市場規模の推定と予測
8 北米のアレルギー免疫療法市場分析
8.1 主要な調査結果
8.2 北米のアレルギー免疫療法市場魅力度指数
8.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
8.4 市場規模推定と予測：国別、2023〜2033年の（US$ Mn）
8.5 市場規模推定と予測：治療タイプ別、2023〜2033年（US$ Mn）
8.6 市場規模推定と予測：アレルギータイプ別、2023～2033年 （US$ Mn）
8.7 市場規模推定と予測：流通チャネル別、2023～2033年 （US$ Mn）
8.8 米国のアレルギー免疫療法市場分析
8.9 カナダのアレルギー免疫療法市場分析
9 欧州のアレルギー免疫療法の市場分析
9.1 主要な調査結果
9.2 欧州アレルギー免疫療法市場魅力度指数
9.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
9.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
9.5 市場規模推定と予測：治療タイプ別、2023〜2033年（US$ Mn）
9.6 市場規模推定と予測：アレルギータイプ別、2023～2033年 （US$ Mn）
9.7 市場規模推定と予測：流通チャネル別、2023～2033年 （US$ Mn）
9.8 ドイツのアレルギー免疫療法市場分析
9.9 イギリスのアレルギー免疫療法市場分析
9.10 フランスのアレルギー免疫療法市場分析
9.11 イタリアのアレルギー免疫療法市場分析
9.12 スペインのアレルギー免疫療法市場分析
9.13 ロシアのアレルギー免疫療法市場分析
9.14 その他の欧州のアレルギー免疫療法市場分析
10 アジア太平洋地域のアレルギー免疫療法市場分析
10.1 主要な調査結果
10.2 アジア太平洋地域のアレルギー免疫療法市場魅力度指数
10.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
10.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
10.5 市場規模推定と予測：治療タイプ別、2023〜2033年（US$ Mn）
10.6 市場規模推定と予測：アレルギータイプ別、2023～2033年 （US$ Mn）
10.7 市場規模推定と予測：流通チャネル別、2023～2033年 （US$ Mn）
10.8 日本アレルギー免疫療法市場分析
10.9 中国アレルギー免疫療法市場分析
10.10 インドアレルギー免疫療法市場分析
10.11 オーストラリアアレルギー免疫療法市場分析
10.12 韓国アレルギー免疫療法市場分析
10.13 東南アジアアレルギー免疫療法市場分析
10.14 その他のアジア太平洋地域のアレルギー免疫療法市場分析
11 ラテンアメリカのアレルギー免疫療法市場分析
11.1 主要な調査結果
11.2 ラテンアメリカのアレルギー免疫療法市場魅力度指数
11.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
11.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
11.5 市場規模推定と予測：治療タイプ別、2023〜2033年（US$ Mn）
11.6 市場規模推定と予測：アレルギータイプ別、2023～2033年 （US$ Mn）
11.7 市場規模推定と予測：流通チャネル別、2023～2033年 （US$ Mn）
11.8 ブラジルのアレルギー免疫療法市場分析
11.9 メキシコアレルギー免疫療法市場分析
11.10 アルゼンチンアレルギー免疫療法市場分析
11.11 コロンビアのアレルギー免疫療法市場分析
11.12 その他のラテンアメリカのアレルギー免疫療法市場分析
12 MEAのアレルギー免疫療法の市場分析
12.1 主要な調査結果
12.2 MEAアレルギー免疫療法市場魅力度指数
12.3 市場規模：国別、2023年、2028年、2033年（US$ Mn）
12.4 市場規模推定と予測：国別、2023〜2033年（US$ Mn）
12.5 市場規模推定と予測：治療タイプ別、2023〜2033年（US$ Mn）
12.6 市場規模推定と予測：アレルギータイプ別、2023～2033年 （US$ Mn）
12.7 市場規模推定と予測：流通チャネル別、2023～2033年 （US$ Mn）
12.8 GCCのアレルギー免疫療法市場分析
12.9 南アフリカのアレルギー免疫療法市場分析
12.10 その他のMEAアレルギー免疫療法市場分析
13 主要企業のプロフィール
13.1 Aimmune Therapeutics
13.1.1 会社概要
13.1.2 会社概要
13.1.3 財務分析
13.1.4 製品ベンチマーク
13.2 ALK-Abelló A/S
13.2.1 会社概要
13.2.2 会社概要
13.2.3 製品ベンチマーク
13.3 Adamis Pharmaceuticals Corporation
13.3.1 会社概要
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収入、2017-2022年
13.3.3.2 R＆D、2017-2022年
13.3.4 製品ベンチマーク
13.3.5 戦略的展望
13.4 Allergy Therapeutics
13.4.1 会社概要
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収入、2017-2022年
13.4.3.2 R＆D、2017-2022年
13.4.4 製品ベンチマーク
13.5 Allergopharma
13.5.1 会社概要
13.5.2 会社概要
13.5.3 製品ベンチマーク
13.6 DVB Technologies SA
13.6.1 会社概要
13.6.2 会社概要
13.6.3 財務分析
13.6.3.1 純収入、2017-2022年
13.6.3.2 R＆D、2017年〜2022年
13.6.4 製品ベンチマーク
13.6.5 戦略的展望
13.7 DESENTUM OY
13.7.1 会社概要
13.7.2 会社概要
13.7.3 製品ベンチマーク
13.8 HAL Allergy Group
13.8.1 会社概要
13.8.2 会社概要
13.8.3 製品ベンチマーク
13.9 HISHOH Biopharma
13.9.1 会社概要
13.9.2 会社概要
13.9.3 製品ベンチマーク
13.9.4 戦略的展望
13.10 HollisterStier Allergy (Jubilant Pharma Company)
13.10.1 会社概要
13.10.2 会社概要
13.10.3 製品ベンチマーク
13.11 レティファーマ
13.11.1 会社概要
13.11.2 会社概要
13.11.3 製品ベンチマーク
13.12 Stallergenes Greer
13.12.1 会社概要
13.12.2 会社概要
13.12.3 製品ベンチマーク
13.12.4 戦略的展望
14 結論と提言
14.1 Visiongainからの結びの言葉
14.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Allergy Immunotherapy Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 North America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 North America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Europe Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Europe Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Europe Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Asia-Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Asia-Pacific Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Asia-Pacific Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia-Pacific Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Latin America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 MEA Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Aimmune Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Aimmune Therapeutics: Product Benchmarking
Table 64 ALK-Abelló A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 ALK-Abelló A/S: Product Benchmarking
Table 66 Adamis Pharmaceuticals Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Adamis Pharmaceuticals Corporation: Product Benchmarking
Table 68 Adamis Pharmaceuticals Corporation: Strategic Outlook
Table 69 Allergy Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Allergy Therapeutics: Product Benchmarking
Table 71 Allergopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Allergopharma: Product Benchmarking
Table 73 DVB Technologies SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 DVB Technologies SA: Product Benchmarking
Table 75 DVB Technologies SA: Strategic Outlook
Table 76 DESENTUM OY: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 DESENTUM OY: Product Benchmarking
Table 78 HAL Allergy Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 HAL Allergy Group: Product Benchmarking
Table 80 HISHOH Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 HISHOH Biopharma: Product Benchmarking
Table 82 HISHOH Biopharma: Strategic Outlook
Table 83 HollisterStier Allergy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 HollisterStier Allergy: Product Benchmarking
Table 85 LETIPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 LETIPharma: Product Benchmarking
Table 87 Stallergenes Greer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Stallergenes Greer: Product Benchmarking
Table 89 Stallergenes Greer: Strategic Outlook
図の一覧
Figure 1 Allergy Immunotherapy Market Segmentation
Figure 2 Allergy Immunotherapy Market by Treatment Type: Market Attractiveness Index
Figure 3 Allergy Immunotherapy Market by Allergy Type: Market Attractiveness Index
Figure 4 Allergy Immunotherapy Market by Distribution Channel: Market Attractiveness Index
Figure 5 Allergy Immunotherapy Market Attractiveness Index by Region
Figure 6 Allergy Immunotherapy Market: Market Dynamics
Figure 7 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 8 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 9 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 10 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 11 Allergy Immunotherapy Market: Porter’s Five Forces Analysis
Figure 12 Allergy Immunotherapy Market: PEST Analysis
Figure 13 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
Figure 14 Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 15 Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
Figure 16 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 17 Subcutaneous Immunotherapy (SCIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Sublingual Immunotherapy (SLIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
Figure 21 Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 22 Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023, 2028, 2033 (%)
Figure 23 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Allergic Rhinitis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Asthma Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Allergy Immunotherapy Market Attractiveness Index by Distribution Channel
Figure 30 Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 31 Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023, 2028, 2033 (%)
Figure 32 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Hospital Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Retail Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Online Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Allergy Immunotherapy Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 39 Allergy Immunotherapy Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 40 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 North America Allergy Immunotherapy Market Attractiveness Index
Figure 42 North America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 43 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 44 North America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 North America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 47 North America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 48 North America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 49 North America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 50 North America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 51 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 53 Europe Allergy Immunotherapy Market Attractiveness Index
Figure 54 Europe Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 55 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 56 Europe Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 57 Europe Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 58 Europe Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 59 Europe Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 61 Europe Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 63 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 64 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 65 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 67 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 68 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
Figure 71 Asia Pacific Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 72 Asia Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 73 Asia Pacific Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 74 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 75 Asia Pacific Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 76 Asia Pacific Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 77 Asia Pacific Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 78 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 79 Asia Pacific Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 80 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Latin America Allergy Immunotherapy Market Attractiveness Index
Figure 88 Latin America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 89 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 90 Latin America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 91 Latin America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 92 Latin America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 93 Latin America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 95 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 97 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 MEA Allergy Immunotherapy Market Attractiveness Index
Figure 103 MEA Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 104 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 105 MEA Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 MEA Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 108 MEA Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 110 MEA Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 112 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 114 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Adamis Pharmaceuticals Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 116 Adamis Pharmaceuticals Corporation: R&D, 2017-2022 (US$ Million, AGR%)
Figure 117 Allergy Therapeutics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 118 Allergy Therapeutics: R&D, 2017-2022 (US$ Million, AGR%)
Figure 119 DVB Technologies SA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 120 DVB Technologies SA: R&D, 2017-2022 (US$ Million, AGR%)
ページTOPに戻る
Summary
Report Details
The Allergy Immunotherapy Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Significant advancements in allergy immunotherapy techniques have propelled the industry forward. The introduction of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) has expanded treatment options, making immunotherapy more accessible and convenient for patients. Additionally, the development of allergen-specific immunotherapies and modified formulations, such as recombinant allergens and adjuvants, has improved treatment efficacy and safety.
Rising healthcare expenditure, particularly in developed countries, has contributed to the growth of the allergy immunotherapy industry. As individuals and healthcare systems prioritize preventive care and long-term management of chronic conditions, allergy immunotherapy has gained recognition as a cost-effective approach. This has fuelled investments in research, innovation, and infrastructure to meet the growing demand.
What Questions Should You Ask before Buying a Market Research Report?
• How is the allergy immunotherapy market evolving?
• What is driving and restraining the allergy immunotherapy market?
• How will each allergy immunotherapy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each allergy immunotherapy submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading allergy immunotherapy markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the allergy immunotherapy projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
allergy immunotherapy projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the allergy immunotherapy market?
• Where is the allergy immunotherapy market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the allergy immunotherapy market today, and over the next 10 years:
• Our 187-page report provides 89 tables and 120 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the allergy immunotherapy market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Treatment Type
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
Allergy Type
• Allergic Rhinitis
• Asthma
• Others
Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Allergy Immunotherapy Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Aimmune Therapeutics
• ALK-Abelló A/S
• Adamis Pharmaceuticals Corporation
• Allergy Therapeutics
• Allergopharma
• DBV Technologies
• DESENTUM OY
• HAL Allergy B.V.
• HISHOH Biopharma
• HollisterStier Allergy (Jubilant Pharma Company)
• LETI Pharma
• Stallergenes Greer
Overall world revenue for Allergy Immunotherapy Market, 2023 to 2033 in terms of value the market will surpass US$2,021.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Allergy Immunotherapy Market, 2023 to 2033 report help you?
In summary, our 180+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Allergy Immunotherapy Market, 2023 to 2033 Market, with forecasts for treatment type, allergy type, and distribution channel each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Allergy Immunotherapy Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 12 of the major companies involved in the Allergy Immunotherapy Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Allergy Immunotherapy Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Allergy Immunotherapy Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Burden of Various Types of Allergies
3.2.1.2 Launch of New Sublingual Immunotherapies in Emerging Economies
3.2.1.3 Increasing Allergic Rhinitis and Asthma Cases
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Awareness about Allergy and Treatments
3.2.2.2 Drawbacks Associated with the use of Allergy Immunotherapy
3.2.3 Market Opportunities
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Buyer Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Allergy Immunotherapy Market Analysis by Treatment Type
4.1 Key Findings
4.2 Treatment Type Segment: Market Attractiveness Index
4.3 Allergy Immunotherapy Market Size Estimation and Forecast by Treatment Type
4.4 Subcutaneous Immunotherapy (SCIT)
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Sublingual Immunotherapy (SLIT)
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Allergy Immunotherapy Market Analysis by Allergy Type
5.1 Key Findings
5.2 Allergy Type Segment: Market Attractiveness Index
5.3 Allergy Immunotherapy Market Size Estimation and Forecast by Allergy Type
5.4 Allergic Rhinitis
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Asthma
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Others
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 Allergy Immunotherapy Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment: Market Attractiveness Index
6.3 Allergy Immunotherapy Market Size Estimation and Forecast by Distribution Channel
6.4 Hospital Pharmacy
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Retail Pharmacy
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Online Pharmacy
6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Allergy Immunotherapy Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Allergy Immunotherapy Market Analysis
8.1 Key Findings
8.2 North America Allergy Immunotherapy Market Attractiveness Index
8.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
8.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
8.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
8.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
8.8 U.S. Allergy Immunotherapy Market Analysis
8.9 Canada Allergy Immunotherapy Market Analysis
9 Europe Allergy Immunotherapy Market Analysis
9.1 Key Findings
9.2 Europe Allergy Immunotherapy Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
9.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
9.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
9.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
9.8 Germany Allergy Immunotherapy Market Analysis
9.9 UK Allergy Immunotherapy Market Analysis
9.10 France Allergy Immunotherapy Market Analysis
9.11 Italy Allergy Immunotherapy Market Analysis
9.12 Spain Allergy Immunotherapy Market Analysis
9.13 Russia Allergy Immunotherapy Market Analysis
9.14 Rest of Europe Allergy Immunotherapy Market Analysis
10 Asia Pacific Allergy Immunotherapy Market Analysis
10.1 Key Findings
10.2 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
10.8 Japan Allergy Immunotherapy Market Analysis
10.9 China Allergy Immunotherapy Market Analysis
10.10 India Allergy Immunotherapy Market Analysis
10.11 Australia Allergy Immunotherapy Market Analysis
10.12 South Korea Allergy Immunotherapy Market Analysis
10.13 South-East Asia Allergy Immunotherapy Market Analysis
10.14 Rest of Asia Pacific Allergy Immunotherapy Market Analysis
11 Latin America Allergy Immunotherapy Market Analysis
11.1 Key Findings
11.2 Latin America Allergy Immunotherapy Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
11.8 Brazil Allergy Immunotherapy Market Analysis
11.9 Mexico Allergy Immunotherapy Market Analysis
11.10 Argentina Allergy Immunotherapy Market Analysis
11.11 Colombia Allergy Immunotherapy Market Analysis
11.12 Rest of Latin America Allergy Immunotherapy Market Analysis
12 MEA Allergy Immunotherapy Market Analysis
12.1 Key Findings
12.2 MEA Allergy Immunotherapy Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Treatment Type, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Allergy Type, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Distribution Channel, 2023-2033 (US$ Mn)
12.8 GCC Allergy Immunotherapy Market Analysis
12.9 South Africa Allergy Immunotherapy Market Analysis
12.10 Rest of MEA Allergy Immunotherapy Market Analysis
13 Company Profiles
13.1 Aimmune Therapeutics
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.4 Product Benchmarking
13.2 ALK-Abelló A/S
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Product Benchmarking
13.3 Adamis Pharmaceuticals Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2022
13.3.3.2 R&D, 2017-2022
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Allergy Therapeutics
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2022
13.4.3.2 R&D, 2017-2022
13.4.4 Product Benchmarking
13.5 Allergopharma
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product Benchmarking
13.6 DVB Technologies SA
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2022
13.6.3.2 R&D, 2017-2022
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 DESENTUM OY
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 HAL Allergy Group
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 HISHOH Biopharma
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.9.4 Strategic Outlook
13.10 HollisterStier Allergy (Jubilant Pharma Company)
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.11 LETIPharma
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.12 Stallergenes Greer
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product Benchmarking
13.12.4 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Allergy Immunotherapy Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
Table 2 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Allergy Immunotherapy Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 North America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 North America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Europe Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Europe Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Europe Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Asia-Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Asia-Pacific Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Asia-Pacific Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia-Pacific Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Latin America Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Latin America Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA Allergy Immunotherapy Market Forecast by Indication, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA Allergy Immunotherapy Market Forecast by Study Design, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 MEA Allergy Immunotherapy Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Aimmune Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Aimmune Therapeutics: Product Benchmarking
Table 64 ALK-Abelló A/S: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 ALK-Abelló A/S: Product Benchmarking
Table 66 Adamis Pharmaceuticals Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Adamis Pharmaceuticals Corporation: Product Benchmarking
Table 68 Adamis Pharmaceuticals Corporation: Strategic Outlook
Table 69 Allergy Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Allergy Therapeutics: Product Benchmarking
Table 71 Allergopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Allergopharma: Product Benchmarking
Table 73 DVB Technologies SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 DVB Technologies SA: Product Benchmarking
Table 75 DVB Technologies SA: Strategic Outlook
Table 76 DESENTUM OY: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 DESENTUM OY: Product Benchmarking
Table 78 HAL Allergy Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 HAL Allergy Group: Product Benchmarking
Table 80 HISHOH Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 HISHOH Biopharma: Product Benchmarking
Table 82 HISHOH Biopharma: Strategic Outlook
Table 83 HollisterStier Allergy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 HollisterStier Allergy: Product Benchmarking
Table 85 LETIPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 LETIPharma: Product Benchmarking
Table 87 Stallergenes Greer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Stallergenes Greer: Product Benchmarking
Table 89 Stallergenes Greer: Strategic Outlook
List of Figures
Figure 1 Allergy Immunotherapy Market Segmentation
Figure 2 Allergy Immunotherapy Market by Treatment Type: Market Attractiveness Index
Figure 3 Allergy Immunotherapy Market by Allergy Type: Market Attractiveness Index
Figure 4 Allergy Immunotherapy Market by Distribution Channel: Market Attractiveness Index
Figure 5 Allergy Immunotherapy Market Attractiveness Index by Region
Figure 6 Allergy Immunotherapy Market: Market Dynamics
Figure 7 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 8 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 9 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 10 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 11 Allergy Immunotherapy Market: Porter’s Five Forces Analysis
Figure 12 Allergy Immunotherapy Market: PEST Analysis
Figure 13 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
Figure 14 Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 15 Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
Figure 16 Subcutaneous Immunotherapy (SCIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 17 Subcutaneous Immunotherapy (SCIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Sublingual Immunotherapy (SLIT) Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Sublingual Immunotherapy (SLIT) Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Allergy Immunotherapy Market Attractiveness Index by Treatment Type
Figure 21 Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 22 Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023, 2028, 2033 (%)
Figure 23 Allergic Rhinitis Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Allergic Rhinitis Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Asthma Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Asthma Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Allergy Immunotherapy Market Attractiveness Index by Distribution Channel
Figure 30 Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 31 Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023, 2028, 2033 (%)
Figure 32 Hospital Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Hospital Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Retail Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Retail Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Online Pharmacy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Online Pharmacy Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Allergy Immunotherapy Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 39 Allergy Immunotherapy Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 40 Allergy Immunotherapy Market by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 North America Allergy Immunotherapy Market Attractiveness Index
Figure 42 North America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 43 North America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 44 North America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 North America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 47 North America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 48 North America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 49 North America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 50 North America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 51 U.S. Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 Canada Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 53 Europe Allergy Immunotherapy Market Attractiveness Index
Figure 54 Europe Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 55 Europe Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 56 Europe Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 57 Europe Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 58 Europe Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 59 Europe Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 61 Europe Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 63 Germany Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 64 UK Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 65 France Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 Italy Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 67 Spain Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 68 Russia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 Rest of Europe Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 Asia Pacific Allergy Immunotherapy Market Attractiveness Index
Figure 71 Asia Pacific Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 72 Asia Pacific Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 73 Asia Pacific Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 74 Asia Pacific Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 75 Asia Pacific Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 76 Asia Pacific Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 77 Asia Pacific Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 78 Asia Pacific Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 79 Asia Pacific Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 80 Japan Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 China Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 India Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Australia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 South Korea Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 South-East Asia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 Rest of Asia Pacific Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Latin America Allergy Immunotherapy Market Attractiveness Index
Figure 88 Latin America Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 89 Latin America Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 90 Latin America Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 91 Latin America Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 92 Latin America Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 93 Latin America Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 95 Latin America Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 97 Brazil Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Mexico Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Argentina Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Colombia Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Latin America Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 MEA Allergy Immunotherapy Market Attractiveness Index
Figure 103 MEA Allergy Immunotherapy Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 104 MEA Allergy Immunotherapy Market Forecast by Country, 2023-2033 (US$ Million)
Figure 105 MEA Allergy Immunotherapy Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 MEA Allergy Immunotherapy Market Forecast by Treatment Type, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA Allergy Immunotherapy Market Share Forecast by Treatment Type, 2023 & 2033 (%)
Figure 108 MEA Allergy Immunotherapy Market Forecast by Allergy Type, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA Allergy Immunotherapy Market Share Forecast by Allergy Type, 2023 & 2033 (%)
Figure 110 MEA Allergy Immunotherapy Market Forecast by Distribution Channel, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA Allergy Immunotherapy Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
Figure 112 GCC Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 South Africa Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 114 Rest of MEA Allergy Immunotherapy Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Adamis Pharmaceuticals Corporation: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 116 Adamis Pharmaceuticals Corporation: R&D, 2017-2022 (US$ Million, AGR%)
Figure 117 Allergy Therapeutics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 118 Allergy Therapeutics: R&D, 2017-2022 (US$ Million, AGR%)
Figure 119 DVB Technologies SA: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 120 DVB Technologies SA: R&D, 2017-2022 (US$ Million, AGR%)
ページTOPに戻る
本レポートと同じKEY WORD（asthma）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
